Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Factor VIII C2 Domain Epitopes Recognized By Classical and Non-Classical Anti-C2 Domain Monoclonal Antibodies Help Mediate FVIII Uptake By Dendritic Cells

Glaivy Batsuli, MD, Wallace Hunter Baldwin, BS, John F Healey, BS, Ernest T Parker, BS, Courtney Cox, MSc, Pete Lollar, MD, Shannon L. Meeks, MD

Blood (2016) 128 (22): 3762.

https://doi.org/10.1182/blood.V128.22.3762.3762

Published: 2016

Journal Articles

Frequency and Epitope Specificity of Anti-Factor VIII C1 Domain Antibodies in Acquired and Hereditary Hemophilia Inhibitor Patient Plasma

Joerg Kahle, PhD, Aleksander Orlowski, Anja Schmidt, PhD, Kerstin Brettschneider, Thomas Klingebiel, MD, John F Healey, BS, Ernest T Parker, BA, John (Pete) S Lollar, MD, Marc Jacquemin, MD, Manuela Krause, MD, Andreas Tiede, MD PhD, Dirk Schwabe, MD, Christoph Königs, MD PhD

Blood (2015) 126 (23): 3491.

https://doi.org/10.1182/blood.V126.23.3491.3491

Published: 2015

Journal Articles

Proteolytically Inactivatable Factor VIII is Less Immunogenic than Factor VIII in a Murine Hemophilia A Model.

Shannon Meeks, MD, Ernest T Parker, BS, Amy L. Dunn, MD, John F Healey, BS, Pete Lollar, MD

Blood (2009) 114 (22): 27.

https://doi.org/10.1182/blood.V114.22.27.27

Published: 2009

Journal Articles

Comparative Decay Rates of Human, Rhesus Macaque, Cynomolgus, and Porcine Activated Factor VIII.

John F Healey, BS, Ernest Parker, BS, John (Pete) S. Lollar, MD

Blood (2009) 114 (22): 3164.

https://doi.org/10.1182/blood.V114.22.3164.3164

Published: 2009

Journal Articles

A Subset of High Titer Acquired Hemophilia Patients May Benefit from Treatment with High Dose Factor VIII.

Shannon Meeks, MD, John F Healey, BS, Ernest T Parker, BS, Pete Lollar, MD

Blood (2009) 114 (22): 3476.

https://doi.org/10.1182/blood.V114.22.3476.3476

Published: 2009

Journal Articles

Cooperative Interaction Between Classical and Non-Classical Factor VIII C2 Domain Antibody Epitopes.

Ana G Antun, MD, Shannon L Meeks, MD, John F Healey, BS, Ernest T Parker, BS, Pete Lollar, MD

Blood (2009) 114 (22): 219.

https://doi.org/10.1182/blood.V114.22.219.219

Published: 2009

Journal Articles

Non-Classical Anti-Factor VIII C2 Domain Antibodies Are Pathogenic in a Murine in Vivo Bleeding Model.

Shannon Meeks, MD, John F. Healey, BS, Ernest T. Parker, BS, Rachel T. Barrow, BS, John (Pete) Lollar, MD

Blood (2008) 112 (11): 2027.

https://doi.org/10.1182/blood.V112.11.2027.2027

Published: 2008

Journal Articles

Enhanced Anticoagulant Activity of Factor VIII Inhibitors Due to Positive Cooperativity between Two Classes of Anti-Factor VIII C2 Antibodies.

Shannon L. Meeks, MD, John F. Healey, BS, Rachel T. Barrow, BS, Ernest T. Parker, BS, Pete Lollar, MD

Blood (2007) 110 (11): 784.

https://doi.org/10.1182/blood.V110.11.784.784

Published: 2007

Journal Articles

Non-Classical Anti-Factor VIII C2 Domain Inhibitors Are Present in the Plasmas of Most Factor VIII Inhibitor Patients.

Shannon L. Meeks, MD, John F. Healey, BS, Rachel T. Barrow, BS, Ernest T. Parker, BS, Pete Lollar

Blood (2007) 110 (11): 786.

https://doi.org/10.1182/blood.V110.11.786.786

Published: 2007

NARROW

Factor VIII C2 Domain Epitopes Recognized By Classical and Non-Classical Anti-C2 Domain Monoclonal Antibodies Help Mediate FVIII Uptake By Dendritic Cells

Frequency and Epitope Specificity of Anti-Factor VIII C1 Domain Antibodies in Acquired and Hereditary Hemophilia Inhibitor Patient Plasma

Proteolytically Inactivatable Factor VIII is Less Immunogenic than Factor VIII in a Murine Hemophilia A Model.

Comparative Decay Rates of Human, Rhesus Macaque, Cynomolgus, and Porcine Activated Factor VIII.

A Subset of High Titer Acquired Hemophilia Patients May Benefit from Treatment with High Dose Factor VIII.

Cooperative Interaction Between Classical and Non-Classical Factor VIII C2 Domain Antibody Epitopes.

Non-Classical Anti-Factor VIII C2 Domain Antibodies Are Pathogenic in a Murine in Vivo Bleeding Model.

Enhanced Anticoagulant Activity of Factor VIII Inhibitors Due to Positive Cooperativity between Two Classes of Anti-Factor VIII C2 Antibodies.

Non-Classical Anti-Factor VIII C2 Domain Inhibitors Are Present in the Plasmas of Most Factor VIII Inhibitor Patients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only